Greater Glasgow and Clyde Medicines

Medicines Update -2021

For all healthcare professionals across NHSGGC both in primary care and the acute sector.

Please note, Medicines Update blogs are correct at the time of publication.

Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact

Click here for further information on Medicines Update.

If you would like to contribute to Medicines Update, click here for a guide to blog writing and the checklist to complete prior to submitting a blog to the Communications Subcommittee of ADTC.

COVID-19 Treatment Update - Dec 2021

Posted: Friday, December 10, 2021

Category - Medicines Update

Ronapreve® is now indicated in two distinct patient populations:

Group 1: Patients admitted unwell with COVID-19 who are negative for baseline serum anti-spike (anti-S) antibodies against SARS-CoV-2.

Group 2: Patients with early hospital onset COVID-19 who are at high risk of progression to severe COVID-19 or in whom COVID-19 infection presents a material risk of destabilising a pre-existing condition or illness or compromising recovery from surgery or other hospital procedure.